LY3985297
- Generic Name
- LY3985297
A First-In-Human Study of LY3985297 in Healthy Participants
- First Posted Date
- 2024-05-01
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 153
- Registration Number
- NCT06395012
- Locations
- 🇺🇸
CenExel ACT, Anaheim, California, United States
🇺🇸ICON, Salt Lake City, Utah, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath